CRBP-1 expression in ovarian cancer: A potential therapeutic target

Anticancer Research

Volumn 34, Issue 7, 2014, Pages 3303-3312

  Doldo, Elena ^a   Costanza, Gaetana ^a   Ferlosio, Amedeo ^a   Passeri, Daniela ^a   Bernardini, Sergio ^a   Scioli, Maria Giovanna ^a   Mazzaglia, Donatella ^a   Agostinelli, Sara ^a   Del Bufalo, Donatella ^b   Czernobilsky, Bernard ^c   Orlandi, Augusto ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c Patho Lab Diagnostics   (Israel)

Author keywords

Apoptosis; Gynecological cancer; Ovarian tumor; Retinol; Retinol binding protein

Indexed keywords

CELLULAR RETINOL BINDING PROTEIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN; PROTEIN AKT1; PROTEIN AKT3; PROTEIN FOS; PROTEIN JUN; RETINOID; RETINOL; STAT1 PROTEIN; STAT5A PROTEIN; UNCLASSIFIED DRUG; CELLULAR RETINOL BINDING PROTEIN; PROTEASOME; RETINOL BINDING PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CLONOGENESIS; CONTROLLED STUDY; COPY NUMBER VARIATION; DOWN REGULATION; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; EPITHELIUM CELL; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METHYLATION; OVARY CARCINOMA; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; VERY ELDERLY; BIOSYNTHESIS; CELL GROWTH; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETICS; GYNECOLOGIC CANCER; MCF 7 CELL LINE; METABOLISM; MIDDLE AGED; OVARY TUMOR; TUMOR CELL LINE;

APOPTOSIS; GYNECOLOGICAL CANCER; OVARIAN TUMOR; RETINOL; RETINOL BINDING PROTEIN;

ADULT; AGED; AGED, 80 AND OVER; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DNA METHYLATION; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MCF-7 CELLS; MIDDLE AGED; OVARIAN NEOPLASMS; PROMOTER REGIONS, GENETIC; PROTEASOME ENDOPEPTIDASE COMPLEX; RETINOL-BINDING PROTEINS, CELLULAR; SIGNAL TRANSDUCTION; TISSUE ARRAY ANALYSIS; VITAMIN A;

EID: 84906314069     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Blomhoff R, Green MH, Green JB, Berg T and Norum KR: Vitamin A metabolism: new perspectives on absorption, transport, and storage. Physiol Rev 71: 951-990, 1991.
2. Blomhoff R: Transport and metabolism of vitamin A. Nutr Rev 52: S13-23, 1994.
3. Dolle P, Fraulob V, Kastner P and Chambon P: Developmental expression of murine retinoid X receptor (RXR) genes. Mech Dev 45: 91-104, 1994.
4. Kato M, Blaner WS, Mertz JR, Das K, Kato K and Goodman DS: Influence of retinoid nutritional status on cellular retinol- and cellular retinoic acid-binding protein concentrations in various rat tissues. J Biol Chem 260: 4832-38, 1985.
5. Underwood BA: Vitamin A and cancer prevention conference-an introduction. J Natl Cancer Inst 73: 1371-1372, 1984.
6. Orlandi A, Ferlosio A, Ciucci A, Sesti F, Lifschitz-Mercer B, Gabbiani G, Spagnoli LG and Czernobilsky B: Cellular retinolbinding protein-1 expression in endometrial stromal cells: physiopathological and diagnostic implications. Histopathology 45: 511-17, 2004.
7. Peralta R, Baudis M, Vazquez G, Juarez S, Ortiz R, Decanini H, Hernandez D, Gallegos F, Valdivia A, Pina P and Salcedo M: Increased expression of cellular retinol-binding protein 1 in laryngeal squamous cell carcinoma. J Canc Res and Clinic Oncol 136: 931-938, 2013.
8. Schmitt-Graff A, Ertelt V, Allgaier HP, Koelble K, Olschewski M, Nitschke R, Bochaton-Piallat ML, Gabbiani G and Blum HE: Cellular retinol-binding protein-1 in hepatocellular carcinoma correlates with beta-catenin, Ki-67 index, and patient survival. Hepatology 38: 470-480, 2003.
9. Orlandi A, Ferlosio A, Ciucci A, Francesconi A, Lifschitz-Mercer B, Gabbiani G, Spagnoli LG and Czernobilsky B: Cellular retinol binding protein-1 expression in endometrial hyperplasia and carcinoma: diagnostic and possible therapeutic implications. Mod Pathol 19: 797-803, 2006.
10. Campos B, Centner FS, Bermejo JL, Ali R, Dorsch K, Wan F, Felsberg J, Ahmadi R, Grabe N, Reifenberger G, Unterberg A, Burhenne J and Herold-Mende C: Aberrant expression of retinoic signaling molecules influences patient survival in astrocytic gliomas. Am J Pathol 178: 1953-1964, 2011.
11. Piver MS, Baker TR, Piedmonte M and Sandecki AM: Epidemiology and etiology of ovarian cancer. Semin Oncol 18: 177-85, 2001.
12. Heinonen PK, Kuoppala T, Koskinen T and Punnonen R: Serum vitamins A and E and carotene in patients with gynecologic cancer. Arch Gynecol Obstet 241: 151-56, 1987.
13. Bertone ER, Hankinson SE, Newcomb PA, Rosner B, Willet WC, Stampfer MJ and Egan KM: A population-based case-control study of carotenoid and vitamin A intake and ovarian cancer (United States). Cancer Causes & Control 12 : 83-90, 2001.
14. Fairfield KM, Hankinson SE, Rosner BA, Hunter DJ, Colditz GA and Willett WC: Risk of ovarian carcinoma and consumption of vitamins A, C, and E and specific carotenoids: a prospective analysis. Cancer 92: 2318-2326, 2001.
15. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G and Kallioniemi OP: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-47, 1998.
16. Stasi, MA, Scioli MG., Arcuri G, Mattera GG, Lombardo K, Marcellini M, Riccioni T, De Falco S, Pisano C, Spagnoli LG, Borsini F and Orlandi A: Propionyl-L-carnitine improves postischemic blood flow recovery and arteriogenetic revascularization and reduces endothelial NADPH-oxidase 4-mediated superoxide production. Arteriosclerosis, thrombosis, and vascular biology 30: 426-435, 2010.
17. Ferlosio A, Arcuri G, Doldo E, Scioli MG, De Falco S, Spagnoli LG and Orlandi A: Age-related increase of stem marker expression influences vascular smooth muscle cell properties. Atherosclerosis 224: 51-57, 2012.
18. Orlandi A, Francesconi A, Marcellini M, Di Lascio A and Spagnoli LG: Propionyl-L-carnitine reduces proliferation and potentiates Bax-related apoptosis of aortic intimal smooth muscle cells by modulating nuclear factor-kappaB activity. J Biol Chem 282: 4932-4942, 2007.
19. Orlandi A, Francesconi A, Cocchia D, Corsini A and Spagnoli LG: Phenotypic heterogeneity influences apoptotic susceptibility to retinoic acid and cis-platinum of rat arterial smooth muscle cells in vitro: Implications for the evolution of experimental intimal thickening. Arterioscler Thromb Vasc Biol 21: 1118-23, 2001.
20. Esteller M, Guo M, Moreno V, Peinado MA, Capella G, Galm O, Baylin SB and Herman JG: Hypermethylation-associated Inactivation of the Cellular Retinol-Binding-Protein 1 Gene in Human Cancer. Cancer Res 62: 5902-5905, 2002
21. Bernardini S, Miano R, Iori R, Finazzi-Agro E, Palmieri G, Ballerini S, Angeloni C, Orlandi A, Bellincampi A, Cortese C and Federici G: Hypermethylation of the CpG islands in the promoter region of the GSTP1 gene in prostate cancer: a useful diagnostic and prognostic marker? Clin Chim Acta 350: 181-188, 2004.
22. Campagnolo L, Costanza G, Francesconi A, Arcuri G, Moscatelli I and Orlandi A: Sortilin expression is essential for pro-nerve growth factor-induced apoptosis of rat vascular smooth muscle cells. PloS One 9: e84969, 2014.
23. Cervelli V, Scioli MG, Gentile P, Doldo E, Bonanno E, Spagnoli LG and Orlandi A: Platelet-rich plasma greatly potentiates insulininduced adipogenic differentiation of human adipose-derived stem cells through a serine/threonine kinase Akt-dependent mechanism and promotes clinical fat graft maintenance. Stem Cells Translational Medicine 1: 206-220, 2012.
24. Franken NA, Rodermond HM, Stap J, Haveman J and van Bree C: Clonogenic assay of cells in vitro 1: 2315-2319, 2006.
25. Orlandi A, Ehrlich HP, Ropraz P, Spagnoli LG and Gabbiani G: Rat aortic smooth muscle cells isolated from different layers and at different times after endothelial denudation show distinct biological features in vitro. Arterioscler Thromb 14 : 982-89, 1994.
26. Lee DH and Goldberg AL: Selective inhibitors of the proteasomedependent and vacuolar pathways of protein degradation in Saccharomyces cerevisiae. J Biol Chem 271: 27280-84, 1996.
27. Cvetkovic D, Williams SJ and Hamilton TC: Loss of cellular retinol-binding protein 1 gene expression in microdissected human ovarian cancer. Clin Cancer Res 9 : 1013-1020, 2003.
28. Kuppumbatti YS, Bleiweiss IJ, Mandeli JP, Waxman S and Mira YLR: Cellular retinol-binding protein expression and breast cancer. J Natl Cancer Inst 92: 475-80, 2000.
29. Clement PB and Young RH: Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects. Adv Anam Pathol 9: 145-184, 2002.
30. Ellenson LH and Wu TC: Focus on endometrial and cervical cancer. Cancer Cell 5: 533-538, 2004.
31. Bokhman JV: Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15: 10-17, 1983.
32. Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P and Prat J: Molecular pathology of endometrial hyperplasia and carcinoma. Hum Pathol 32: 569-77, 2001.
33. Jeronimo C, Henrique R, Oliveira J, Lobo F, Pais I, Teixeira MR and Lopes C: Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer. J Clin Pathol 57: 872-876, 2004.
34. Mendoza-Rodriguez M, Arreola H, Valdivia A, Peralta R, Serna H, Villegas V, Romero P, Alvarado-Hernandez B, Paniagua L, Marrero-Rodriguez D, Meraz MA and Salcedo M: Cellular retinol binding protein 1 could be a tumor suppressor gene in cervical cancer. Int J Clin Exp Pathol 6: 1817-1825, 2013.
35. Morris EJ, Dreixler JC, Cheng KY, Wilson PM, Gin RM and Geller HM: Optimization of single-cell gel electrophoresis (SCGE) for quantitative analysis of neuronal DNA damage. Biotechniques 26: 282-283, 286-289, 1999.
36. Napoli JL, Posch KP, Fiorella PD and Boerman MH: Physiological occurrence, biosynthesis and metabolism of retinoic acid: evidence for roles of cellular retinol-binding protein (CRBP) and cellular retinoic acid-binding protein (CRABP) in the pathway of retinoic acid homeostasis. Biomed Pharmacother 45: 131-43, 1991.
37. Ong DE: Cellular transport and metabolism of vitamin A: roles of the cellular retinoid-binding proteins. Nutr Rev 52: S24-31, 1994.
38. Husmann M, Hoffmann B, Stump DG, Chytil F and Pfahl M: A retinoic acid response element from the rat CRBPI promoter is activated by an RAR/RXR heterodimer. Biochem Biophys Res Commun 187: 1558-64,1992.
39. Garattini E, Bolis M, Garattini SK, Fratelli M, Centritto F, Paroni G, Gianni M, Zanetti A, Pagani A, Fisher JN, Zambelli A and Terao M: Retinoids and breast cancer: From basic studies to the clinic and back again. Cancer Treat Rev (epub head of print), 2014.
40. Siddikuzzaman, Guruvayoorappan C and Berlin Grace VM: All trans retinoic acid and cancer. Immunopharmacol and Immunotoxicol 33: 241-249, 2011.
41. Supino R, Crosti M, Clerici M, Warlters A, Cleris L, Zunino F and Formelli F: Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression. IntJ Cancer 65: 491-497, 1996.
42. Farias E, Ong D, Ghyselinck N, Nakajo S, Kuppumbatti Y, Mira y Lopez R: Cellular retinol-binding protein I, a regulator of breast epithelial retinoic acid receptor activity, cell differentiation, and tumorigenicity. J Natl Cancer Inst 97: 21-29, 2005.
43. Yasmeen A, Beauchamp MC, Piura E, Segal E, Pollak M and Gotlieb WH: Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins. Gynecol Oncol 121: 492-498, 2011.
44. Correa RJ, Ramos Valdes Y, Peart TM, Fazio EN, Bertrand M, McGee J, Prefontaine M, Sugimoto A, Dimattia GE and Shepherd TG: Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability. Carcinogenesis (epub head of print), 2014.
45. Surh YJ: Cancer chemoprevention with dietary phytochemicals. Cancer 3: 768-780, 2003.
46. Ciuffreda L, Di Sanza C, Cesta Incani U, Eramo A, Desideri, M, Biagioni F, Passeri D, Falcone I, Sette G, Bergamo P, Anichini A, Sabapathy K, McCubrey JA, Ricciardi MR, Tafuri A, Blandino G, Orlandi A, De Maria R, Cognetti F, Del Bufalo D, and Milella M: The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanisms. Journal of molecular medicine 90: 667-679, 2012.
47. Farias E, Marzan C and Mira-y-Lopez R: Cellular retinol-binding protein-I inhibits PI3K/Akt signaling through a retinoic acid receptor-dependent mechanism that regulates p85-p110 heterodimerization. Oncogene 24: 1598-1606, 2005.
48. Scioli MG, Bielli A, Gentile P, Mazzaglia D, Cervelli, V, and Orlandi A: The biomolecular basis of adipogenic differentiation of adipose-derived stem cells. International journal of molecular sciences 15: 6517-6526, 2014.
49. Heuser M, Sly LM, Argiropoulos B, Kuchenbauer F, Lai C, Weng A, Leung M, Lin G, Brookes C, Fung S, Valk PJ, Delwel R, Lowenberg B, Krystal G and Humphries RK: Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal. Blood 114: 3983-3993, 2009.
50. Eckhoff K, Flurschutz R, Trillsch F, Mahner S, Janicke F and Milde-Langosch K: The prognostic significance of Jun transcription factors in ovarian cancer. J Cancer Res Clin Oncol 139: 1673-1680, 2013.
51. Roberts PJ and Der CJ: Targeting the Raf-MEK-ERK mitogenactivated protein kinase cascade for the treatment of cancer. Oncogene 26: 3291-3310, 2007.
52. Glickman MH and Ciechanover A: The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82: 373-428, 2002.
53. Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, Wu P, Wiesmann C, Baker R, Boone DL, Ma A, Koonin EV and Dixit VM: De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430: 694-699, 2004.